NM_000179.3(MSH6):c.698dup (p.Pro233_Lys234insTer) AND Lynch syndrome 5

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Aug 10, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003451219.1

Allele description [Variation Report for NM_000179.3(MSH6):c.698dup (p.Pro233_Lys234insTer)]

NM_000179.3(MSH6):c.698dup (p.Pro233_Lys234insTer)

Gene:

MSH6:mutS homolog 6 [Gene - OMIM - HGNC]

Variant type:

Duplication

Cytogenetic location:

2p16.3

Genomic location:

Preferred name:

NM_000179.3(MSH6):c.698dup (p.Pro233_Lys234insTer)

HGVS:

NC_000002.12:g.47798681dup
NG_007111.1:g.20535dup
NM_000179.3:c.698dupMANE SELECT
NM_001281492.2:c.308dup
NM_001281493.2:c.-209dup
NM_001281494.2:c.-209dup
NP_000170.1:p.Pro233_Lys234insTer
NP_001268421.1:p.Pro103_Lys104insTer
LRG_219:g.20535dup
NC_000002.11:g.48025820dup
NM_000179.2:c.698dupC

Links:

dbSNP: rs1553412120

NCBI 1000 Genomes Browser:

rs1553412120

Molecular consequence:

NM_001281493.2:c.-209dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001281494.2:c.-209dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_000179.3:c.698dup - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001281492.2:c.308dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:: Lynch syndrome 5 (LYNCH5)
Synonyms:: Colorectal cancer, hereditary nonpolyposis, type 5; Hereditary non-polyposis colorectal cancer, type 5
Identifiers:: MONDO: MONDO:0013710; MedGen: C1833477; Orphanet: 144; OMIM: 614350

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004187320	Myriad Genetics, Inc.	criteria provided, single submitter (Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))	Pathogenic (Aug 10, 2023)	unknown	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004187320

Myriad Genetics, Inc.

criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))

Pathogenic
(Aug 10, 2023)

unknown

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Myriad Genetics, Inc., SCV004187320.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 8, 2024

ClinVar

Relating variation to medicine